These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 7715073)

  • 21. Tetraploidy and 5q deletion in myelodysplastic syndrome: a case report.
    Znoyko I; Stuart RK; Ellingham T; Winters J; Wolff DJ; Quigley DI
    Cancer Genet Cytogenet; 2008 May; 183(1):64-8. PubMed ID: 18474300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Busulfan, cyclophosphamide and melphalan as conditioning regimen for bone marrow transplantation in children with myelodysplastic syndromes.
    Locatelli F; Pession A; Bonetti F; Maserati E; Prete L; Pedrazzoli P; Zecca M; Prete A; Paolucci P; Cazzola M
    Leukemia; 1994 May; 8(5):844-9. PubMed ID: 8182940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymphoid blast crisis during interferon-alpha therapy in a patient with chronic myelogenous leukemia in myeloid blast crisis.
    Goto H; Tsurumi H; Hara T; Moriwaki H
    Int J Hematol; 2000 Dec; 72(4):474-6. PubMed ID: 11197215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical aspects of the myelodysplastic syndromes (MDS) with special reference to refractory anemia with excess of blasts (RAEB).
    Omine M; Yamauchi H
    Nihon Ketsueki Gakkai Zasshi; 1989 Jul; 52(4):800-10. PubMed ID: 2618556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluorescence in situ hybridization improves the detection of 5q31 deletion in myelodysplastic syndromes without cytogenetic evidence of 5q-.
    Mallo M; Arenillas L; Espinet B; Salido M; Hernández JM; Lumbreras E; del Rey M; Arranz E; Ramiro S; Font P; González O; Renedo M; Cervera J; Such E; Sanz GF; Luño E; Sanzo C; González M; Calasanz MJ; Mayans J; García-Ballesteros C; Amigo V; Collado R; Oliver I; Carbonell F; Bureo E; Insunza A; Yañez L; Muruzabal MJ; Gómez-Beltrán E; Andreu R; León P; Gómez V; Sanz A; Casasola N; Moreno E; Alegre A; Martín ML; Pedro C; Serrano S; Florensa L; Solé F
    Haematologica; 2008 Jul; 93(7):1001-8. PubMed ID: 18591625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Importance of basophilia in haematopoietic disorders.
    Shibata K; Watanabe M; Yano H; Matsuzaki M; Funai N; Sano M
    Haematologia (Budap); 1998; 29(3):241-53. PubMed ID: 10069449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imatinib mesylate for Philadelphia chromosome-positive, chronic-phase myeloid leukemia after failure of interferon-alpha: follow-up results.
    Kantarjian HM; Talpaz M; O'Brien S; Smith TL; Giles FJ; Faderl S; Thomas DA; Garcia-Manero G; Issa JP; Andreeff M; Kornblau SM; Koller C; Beran M; Keating M; Rios MB; Shan J; Resta D; Capdeville R; Hayes K; Albitar M; Freireich EJ; Cortes JE
    Clin Cancer Res; 2002 Jul; 8(7):2177-87. PubMed ID: 12114418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myelodysplastic syndrome accompanied by basophilia and eosinophilia with t(5;12)(q31;p13).
    Katsura Y; Suzukawa K; Nanmoku T; Nemoto N; Machino T; Obara N; Okoshi Y; Mukai HY; Hasegawa Y; Kojima H; Kawakami Y; Nagasawa T
    Cancer Genet Cytogenet; 2007 Oct; 178(1):85-8. PubMed ID: 17889716
    [No Abstract]   [Full Text] [Related]  

  • 29. [Alfa-2b interferon in the treatment of thrombocytosis associated to chronic non leukemic myeloproliferative syndromes].
    Petit J; Callís M; Domingo Albós A; Fernández de Sevilla A; Besses C; Martí JM
    Med Clin (Barc); 1993 Nov; 101(16):601-3. PubMed ID: 8271861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytogenetic studies in 32 patients with myelodysplastic syndrome: insights to specific chromosomal abnormalities and prognosis.
    Taniwaki M; Horiike S; Inazawa J; Nishida K; Misawa S; Takino T; Abe T
    Jpn J Clin Oncol; 1987 Jun; 17(2):141-50. PubMed ID: 3613138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapy-related myelodysplastic syndrome with monosomy 5 after successful treatment of acute myeloid leukemia (M2).
    Ogasawara T; Yasuyama M; Kawauchi K
    Am J Hematol; 2005 Jun; 79(2):136-41. PubMed ID: 15929101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Myelodysplastic syndrome developing acute myelocytic leukemia with gastric mucormycosis].
    Sasaki A; Tsukaguchi M; Takayasu K; Hanai J
    Rinsho Byori; 1993 Sep; 41(9):1054-8. PubMed ID: 8254969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical biological features of mixed myeloid diseases].
    Gritsaev SV; Abldulkadyrov KM; Tiranova SA; Kapustin SI; Martynkevich IS; Bessmel'tsev SS; Rugal' VI; Bakaĭ MP
    Ter Arkh; 2004; 76(12):68-73. PubMed ID: 15724931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interferon alpha-2a to control thrombocytosis in chronic myelogenous leukemia and essential thrombocythemia.
    Jootar S
    Asian Pac J Allergy Immunol; 1989 Dec; 7(2):103-5. PubMed ID: 2624663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of five prognostic scoring systems, the French-American-British (FAB) and World Health Organization (WHO) classifications in patients with myelodysplastic syndromes: Results of a single-center analysis.
    Müller-Berndorff H; Haas PS; Kunzmann R; Schulte-Mönting J; Lübbert M
    Ann Hematol; 2006 Aug; 85(8):502-13. PubMed ID: 16715299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Karyotype is prognostically more important than the FAB system's distinction between myelodysplastic syndrome and acute myelogenous leukemia.
    Estey EH; Keating MJ; Dixon DO; Trujillo JM; McCredie KB; Freireich EJ
    Hematol Pathol; 1987; 1(4):203-8. PubMed ID: 3504436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel karyotype in acute myeloid leukemia with basophilia.
    Servitzoglou M; Grenzelia M; Baka M; Harisi M; Pourtsidis A; Bouhoutsou D; Varvoutsi M; Doganis D; Dana H; Divane A; Kosmidis H
    Pediatr Hematol Oncol; 2014 Mar; 31(2):149-56. PubMed ID: 24552500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone marrow morphology predicts additional chromosomal abnormalities in patients with myelodysplastic syndrome with del(5q).
    Geyer JT; Verma S; Mathew S; Wang YL; Racchumi J; Espinal-Witter R; Subramaniyam S; Knowles DM; Orazi A
    Hum Pathol; 2013 Mar; 44(3):346-56. PubMed ID: 22995330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Discrepancy in karyotypes between peripheral blood and bone marrow during blastic crisis in chronic myelocytic leukemia].
    Maeda T; Ashie T; Kikuiri K; Ishiyama N; Takakura M
    Rinsho Ketsueki; 1989 Jul; 30(7):1032-6. PubMed ID: 2810787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Limited activity of mini-dose interferon alpha-2a in the treatment of myelodysplastic syndrome.
    Maerevoet M; Van Den Neste E; Delannoy A; Ferrant A; Martiat P; Bosly A; Fauchet M; Michaux JL
    Leuk Lymphoma; 1996 May; 21(5-6):519-20. PubMed ID: 9172821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.